Midline Catheter Market Report: Market Size & Forecast 2026

Midline catheters represent a critical category within the broader vascular access market, designed for patients requiring intermediate-duration intravenous therapy typically lasting between one and four weeks. These devices are inserted into peripheral veins of the upper arm and extend to the distal subclavian vein, offering a safer alternative to central venous catheters for many clinical applications. The global market is valued at approximately $220 million in 2025 and is expected to reach around $265 million by 2030.

• •Market valued at approximately $220 million in 2025
• •Projected to reach approximately $265 million by 2030
• •Growing at a CAGR of 5% over the forecast period

The primary driver of market expansion is the growing preference for midline catheters over traditional central venous catheters due to their lower risk of bloodstream infections and pneumothorax. An aging global population with increasing prevalence of chronic conditions such as cancer, diabetes, and kidney disease has escalated demand for reliable long-term vascular access solutions. Healthcare cost containment initiatives also favor midline catheters, as they reduce complications and associated treatment expenses compared to central line alternatives.

• •Lower complication rates compared to central venous catheters
• •Rising prevalence of chronic diseases requiring long-term IV therapy
• •Cost-effectiveness driving hospital adoption

The market is segmented by product type, including standard midline catheters and antimicrobial or antimicrobial-coated variants designed to reduce infection risk. North America currently leads the global market due to advanced healthcare infrastructure, high adoption rates of innovative medical devices, and established reimbursement frameworks. The Asia-Pacific region is anticipated to witness the fastest growth, driven by expanding healthcare access, rising medical tourism, and increasing investments in hospital infrastructure across emerging economies.

• •North America holds the largest market share
• •Asia-Pacific expected to show the fastest growth rate
• •Segmentation includes standard and antimicrobial-coated catheter variants

What are the recent trends and outlook?

Emerging trends include increased adoption of antimicrobial and antithrombotic coatings to enhance patient safety and reduce catheter-related complications. The integration of ultrasound-guided insertion techniques is improving first-stick success rates and reducing insertion complications. Over the forecast period, the market is expected to benefit from ongoing clinical research demonstrating midline catheter efficacy, expanded indications for use, and growing nursing specialization in intravenous therapy across hospital networks worldwide.

• •Growing adoption of antimicrobial-coated midline catheters
• •Ultrasound-guided insertion becoming standard practice
• •Specialized IV nursing teams driving proper utilization and management